# Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)

Study · id `cardio:ct-nct02826200` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02826200](<https://clinicaltrials.gov/study/NCT02826200>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02826200

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02826200. Randomized; single masking; primary purpose prevention. Start 2016-07 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02826200, source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)
- Start date: 2016-07 (registry gives no type) (ClinicalTrials.gov record NCT02826200, source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)
- Primary completion: 2018-07 (anticipated) (ClinicalTrials.gov record NCT02826200, source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)
- Completion: 2019-01 (anticipated) (ClinicalTrials.gov record NCT02826200, source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)
- Countries: Hungary (ClinicalTrials.gov record NCT02826200, source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02826200-2017-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)
- Acronym: RETORIC
- Condition: Prosthetic Cardiac Valve Thrombosis
- Condition: Cerebrovascular Accident
- Condition: Prosthetic Valve Malfunction
- Intervention (Drug): Acenocoumarol
- Intervention (Other): Standard of care
- Lead sponsor: Semmelweis University Heart and Vascular Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Semmelweis University Heart and Vascular Center (`cardio:org-semmelweis-university-heart-and-vascular-center`)

## Provenance

Content hash: d6acb498a9c6e45df38377eb83456a804c09e019f2739efbb37bc16f34e1eb60
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
